Table 1. Relationship between characteristics and NLR at pre-CCRT.
| Variables | Low NLR | High NLR | |||||
|---|---|---|---|---|---|---|---|
| n/N (%) | n/N (%) | OR | aOR | 95% CI of aOR | P | ||
| Sex | 0.191 | ||||||
| Female (ref.) | 15/33 (45) | 18/33 (55) | 1.00 | 1.00 | |||
| Male | 25/48 (52) | 23/48 (48) | 0.77 | 0.52 | 0.19–1.39 | ||
| Age (years) | 0.092 | ||||||
| > 51 (ref.) | 17/40 (42) | 23/40 (58) | 1.00 | 1.00 | |||
| ≤ 51 | 23/41 (56) | 18/41 (44) | 0.58 | 0.43 | 0.16–1.15 | ||
| Cancer stage | 0.026 | ||||||
| Stage II (ref.) | 13/21 (62) | 8/21 (38) | 1.00 | 1.00 | |||
| Stage III | 21/38 (55) | 17/38 (45) | 1.32 | 1.27 | 0.42–3.88 | ||
| Stage IVA | 6/22 (27) | 16/22 (73) | 4.33 | 5.72 | 1.45–22.55 | ||
Abbreviations: ref., reference group; OR, odds ratio; aOR, adjusted odds ratio; 95%CI, 95% confidence interval.